Endothelin-1 is increased in the plasma of patients hospitalised with Covid-19

COVID‐19‐induced endotheliitis: emerging evidence and possible therapeutic strategies

(2021) Eleonora Calabretta et al.   BRITISH JOURNAL OF HAEMATOLOGY

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19

(2021) Ryan S Thwaites et al.   Science Immunology

Endothelin Antagonism and Sodium Glucose Co-transporter 2 Inhibition A Potential Combination Therapeutic Strategy for COVID-19

(2021) Marie Fisk et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

COVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanism

(2021) Sharon E. Fox et al.   CARDIOVASCULAR PATHOLOGY

Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19

(2021) L.H. Willems et al.   THROMBOSIS RESEARCH

A rational roadmap for SARS‐CoV‐2/COVID‐19 pharmacotherapeutic research and development. IUPHAR Review 29

(2020) S.P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Endothelial cell infection and endotheliitis in COVID-19

(2020) Zsuzsanna Varga et al.   LANCET

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

(2020) Maximilian Ackermann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

(2020) George Goshua et al.   Lancet Haematology

Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction

(2019) Thomas J Ford et al.   EUROPEAN HEART JOURNAL